The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis.

  title={The effect of thalidomide on corticosteroid-dependent pulmonary sarcoidosis.},
  author={Marc A Judson and Joanne Silvestri and Cindy Hartung and T. Douglas Byars and Christopher E Cox},
  journal={Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG},
  volume={23 1},
STUDY OBJECTIVE To determine the benefit and corticosteroid-sparing potential of thalidomide in corticosteroid-dependent pulmonary sarcoidosis. METHODS The study was a prospective open-label pilot study. Ten subjects were enrolled who had pulmonary sarcoidosis, required corticosteroid therapy for at least six months, and experienced a flare of pulmonary sarcoidosis within the previous 2 years when corticosteroids had been reduced or discontinued. Thalidomide was given at a dose of 200 mg/day… CONTINUE READING